Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations
Support NHPR's local journalism that brings clarity, context, and community!

FDA Approves Slow-Release Painkiller

This product image provided by Purdue Pharma shows Hysingla, the first hard-to-abuse version of the painkiller hydrocodone. The Food and Drug Administration on Thursday, Nov. 20, 2014 approved Hysingla, a once-a-day tablet for patients with severe, round-the-clock pain that cannot be managed with other treatments. (Purdue Pharma via AP)
This product image provided by Purdue Pharma shows Hysingla, the first hard-to-abuse version of the painkiller hydrocodone. The Food and Drug Administration on Thursday, Nov. 20, 2014 approved Hysingla, a once-a-day tablet for patients with severe, round-the-clock pain that cannot be managed with other treatments. (Purdue Pharma via AP)

The FDA has approved a new opioid painkiller that releases over a 24-hour period, and is designed to reduce abuse by people chewing or smashing it into a powder for injection. However, the agency admits that abuse and overdose of the drug Hysingla is still possible.

Michael Regan of Bloomberg News spoke to Here & Now’s Jeremy Hobson about the new drug.

Guest

Copyright 2021 NPR. To see more, visit https://www.npr.org.

You make NHPR possible.

NHPR is nonprofit and independent. We rely on readers like you to support the local, national, and international coverage on this website. Your support makes this news available to everyone.

Give today. A monthly donation of $5 makes a real difference.